221 filings
8-K
ARDS
Aridis Pharmaceuticals, Inc.
16 Jan 24
Submission of Matters to a Vote of Security Holders
6:05am
DEFA14A
ARDS
Aridis Pharmaceuticals, Inc.
18 Dec 23
Additional proxy soliciting materials
9:43am
8-K
ARDS
Aridis Pharmaceuticals, Inc.
18 Dec 23
Amendments to Articles of Incorporation or Bylaws
9:40am
DEFA14A
ARDS
Aridis Pharmaceuticals, Inc.
15 Dec 23
Additional proxy soliciting materials
5:00pm
10-Q
2023 Q3
ARDS
Aridis Pharmaceuticals, Inc.
Quarterly report
6 Nov 23
4:06pm
8-K
po2eyaosrk2e8
3 Nov 23
Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results
5:00pm
DEFA14A
stwc wyk7
3 Nov 23
Additional proxy soliciting materials
6:15am
ARS
4qgfo oamqe53
2 Nov 23
Annual report to shareholders
5:54pm
25-NSE
x11bmm0 el
8 Sep 23
Exchange delisting
10:13am
8-K
jhmt580 pg3qv4vbmw2
7 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
o3n1cw2
25 Aug 23
Termination of a Material Definitive Agreement
4:05pm
8-K
ofym09bhi bm3ril
9 Aug 23
Departure of Directors or Certain Officers
4:15pm
424B5
q755l9
4 Aug 23
Prospectus supplement for primary offering
4:05pm
424B5
i2guqe25 seu8aeuv7yl
4 Aug 23
Prospectus supplement for primary offering
4:05pm
424B5
oddi9w8mhr ybx
3 Aug 23
Prospectus supplement for primary offering
4:15pm
EFFECT
zwzb 87n3bt
2 Aug 23
Notice of effectiveness
12:15am
CORRESP
q1dojn8co xst
31 Jul 23
Correspondence with SEC
12:00am